Advertisement
Advertisement
TEM
Tempus AI, Inc. Class A Common Stock
55.69
USDSponsored
+0.63
+1.14%
Aug 11, 16:00 UTC -4
Closed
After-Market
55.50
-0.19
-0.34%
TEM Earnings Reports
Positive Surprise Ratio
TEM beat 9 of 10 last estimates.
90%
Next Report
Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$414.74M
/-$0.08
Implied change from Q2 26 (Revenue/ EPS)
+8.43%
/+100.00%
Implied change from Q3 25 (Revenue/ EPS)
+24.10%
/-27.27%
Tempus AI, Inc. Class A Common Stock earnings per share and revenue
On Jul 30, 2026, TEM reported earnings of -0.04 USD per share (EPS) for Q2 26, beating the estimate of -0.14 USD, resulting in a 71.65% surprise. Revenue reached 382.49 million, compared to an expected 383.54 million, with a -0.27% difference. The market reacted with a -1.05% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 414.74 million USD, implying an increase of 100.00% EPS, and increase of 8.43% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Hims & Hers Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.01
Actual
-$0.10
Surprise
-599.30%
10x Genomics, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.14
Surprise
+43.09%
iRhythm Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.57
Surprise
>+10,000.00%
Talkspace, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.02
Actual
-$0.01
Surprise
-134.25%
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Evolent Health, Inc Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.02
Surprise
+183.68%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.23
Surprise
+7.67%
Health Catalyst, Inc Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+29.03%
Neuraxis, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.19
Surprise
+41.79%
FAQ
What were Tempus AI, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Tempus AI, Inc. Class A Common Stock reported EPS of -$0.04, beating estimates by 71.65%, and revenue of $382.49M, -0.27% below expectations.
How did the market react to Tempus AI, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved down -1.05%, changed from $54.07 before the earnings release to $53.50 the day after.
When is Tempus AI, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Oct 29, 2026.
What are the forecasts for Tempus AI, Inc. Class A Common Stock's next earnings report?
Based on 13
analysts, Tempus AI, Inc. Class A Common Stock is expected to report EPS of -$0.08 and revenue of $414.74M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement